Tools
Tools
Davies, E, Buckley, BJR, Austin, P, Lip, GYH, Oni, L, McDowell, G and Rao, A (2024) Routine cardiac biomarkers for the prediction of incident major adverse cardiac events in patients with Glomerulonephritis: A real-world analysis using a global federated database. BMC Nephrology, 25.
|
Text
Routine cardiac biomarkers for the prediction of incident major adverse cardiac events in patients with Glomerulonephritis A real-world analysis using a global federated database.pdf - Published Version Available under License Creative Commons Attribution. Download (3MB) | Preview |
Abstract
Rationale & Objective: Glomerulonephritis (GN) is a leading cause of chronic kidney disease (CKD). Major adverse cardiovascular events (MACE) are prolific in CKD. The risk of MACE in GN cohorts is multifactorial. We investigated the prognostic significance of routine cardiac biomarkers, Troponin I and N-terminal pro-BNP (NT-proBNP) in predicting MACE within 5 years of GN diagnosis. Study Design: Retrospective cohort study Setting & Participants: Data were obtained from TriNetX, a global federated health research network of electronic health records (EHR). Exposure or Predictor: Biomarker thresholds: Troponin I: 18 ng/L, NT-proBNP: 400 pg/mL Outcomes: Primary outcome: Incidence of major adverse cardiovascular events (MACE). Secondary outcome: was the risk for each individual component of the composite outcome. Analytical Approach: 1:1 propensity score matching using logistic regression. Cox proportional hazard models were used to assess the association of cardiac biomarkers with the primary and secondary outcomes, reported as Hazard Ratio HR) and 95% confidence intervals CI). Survival analysis was performed which estimates the probability of an outcome over a 5year follow-up from the index event. Results: Following PSM, 34,974 and 18,218 patients were analysed in the Troponin I and NTproBNP cohorts, respectively. In the Troponin I all cause GN cohort, 3,222 (9%) developed composite MACE outcome HR 1.79; (95% CI, 1.70, 1.88, p <0.0001). In the NTproBNP GN cohort, 1,686 (9%) developed composite MACE outcome HR 1.99; (95% CI, 1.86, 2.14, p<0.0001). Limitations: The data are derived from EHR for administrative purposes; therefore, there is the potential for data errors or missing data. Conclusions: In GN, routinely available cardiac biomarkers can predict incident MACE. The results suggest the clinical need for CV mortality and morbidity risk profiling in glomerular disease using a combination of clinical and laboratory variables.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | 1103 Clinical Sciences; Urology & Nephrology |
| Subjects: | R Medicine > RC Internal medicine R Medicine > RS Pharmacy and materia medica |
| Divisions: | Pharmacy & Biomolecular Sciences Psychology (from Sep 2019) Sport & Exercise Sciences |
| Publisher: | BMC |
| SWORD Depositor: | A Symplectic |
| Date Deposited: | 15 Jul 2024 14:08 |
| Last Modified: | 29 Jul 2024 08:30 |
| DOI or ID number: | 10.1186/s12882-024-03667-y |
| URI: | https://researchonline.ljmu.ac.uk/id/eprint/23749 |
 |
View Item |